Inventor
CHEN MING J
US20 patents
⚠️ This page may combine multiple inventors who share the name “CHEN MING J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
OSI SPECIALTIES INC
7 patentsUS5714532AFeb 3, 1998
Composition of epoxysilane emulsion additives in water based reactive polymer dispersions and methods of preparation
OSI SPECIALTIES INC54 citations96
US6127462AOct 3, 2000
Compositions of epoxysilane and reactive polymer with cure catalyst and methods of preparation
OSI SPECIALTIES INC30 citations92
US5621038AApr 15, 1997
Aqueous silylated polymer curable compositions
OSI SPECIALTIES INC28 citations92
US5393330AFeb 28, 1995
Cationic emulsions of alkylalkoxysilanes
OSI SPECIALTIES INC29 citations92
US5686523ANov 11, 1997
Aqueous curable silane/polymer compositions
OSI SPECIALTIES INC48 citations90
US6221938B1Apr 24, 2001
Compositions of epoxysilane and reactive polymer with cure catalyst and methods of preparation
OSI SPECIALTIES INC14 citations73
US5827922AOct 27, 1998
Aqueous silylated polymer curable compositions with tin catalysts
OSI SPECIALTIES INC15 citations73
CHEN MING J
4 patentsUS5297809AMar 29, 1994
Mechanics creeper
CHEN MING J27 citations91
USD325799SApr 28, 1992
Mechanics creeper
CHEN MING J38 citations91
US9757355B2Sep 12, 2017
Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
CHEN MING J0 citations47
US9023886B2May 5, 2015
Nanosuspension of a poorly soluble drug via microfluidization process
CHEN MING J1 citations47
CELGENE CORP
4 patentsUS12064427B2Aug 20, 2024
Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same
CELGENE CORP0 citations52
US11779580B2Oct 10, 2023
Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrtle and methods of using the
CELGENE CORP0 citations52
US9616019B2Apr 11, 2017
Nanosuspension of a poorly soluble drug via microfluidization process
CELGENE CORP0 citations48
US9532977B2Jan 3, 2017
Controlled release oral dosage forms of poorly soluble drugs and uses thereof
CELGENE CORP1 citations45